Literature DB >> 33407761

The protective effects of phosphodiesterase-5 inhibitor, sildenafil on post-resuscitation cardiac dysfunction of cardiac arrest: by regulating the miR-155-5p and miR-145-5p.

Yong He1, Guoxing Wang1, Chuang Li2, Yuxing Wang2, Qian Zhang3.   

Abstract

BACKGROUND: MiRNA-155 and miRNA-145 have been demonstrated to function as a key regulator in the development of the cardiovascular system. Recent experimental and clinical studies have indicated the cardioprotective role of sildenafil during ischemia/reperfusion (I/R) injury. This study was designed to investigate if administration of sildenafil will attenuate post-resuscitation myocardial dysfunction by regulating miRNA-155 and miR-145 expressions.
METHODS: Thirty-two male pigs (weighing 30 ± 2 kg) were randomly divided into 4 groups, sildenafil group (n = 8), sildenafil +NG-nitro-l-arginine methyl ester (L-NAME) (20 mg/kg L) group (n = 8), saline (SA group, n = 8); and sham operation group (sham group, n = 8). Eight minutes of untreated VF was followed by defibrillation in anesthetized, closed-chest pigs. Hemodynamic status and blood samples were obtained at 0 min, 0.5, 1, 2, 4 and 6 h after return of spontaneous circulation (ROSC), and the hearts were removed and analyzed under electron microscopy, quantitative real-time polymerase chain reaction and ultra structural analysis were performed to evaluate myocardial injury.
RESULTS: Compared with the sildenafil + L-NAME and saline groups, the sildenafil group had better outcomes in terms of hemodynamic and oxygen metabolism parameters as well as 24-h survival rate, and attenuated myocardial injury; In this study, CA pigs showed evidently increased levels of miR-155-5p and miR-145-5p, while the sildenafil treatment decreased the levels of miR-155-5p and miR-145-5p in CA pigs. In addition, the levels of eNOS was decreased in CA pigs, validating sildenafil attenuating post-resuscitation myocardial dysfunction by regulating miRNA-155 and miR-145 expressions.
CONCLUSIONS: Sildenafil group had better outcomes in terms of hemodynamic and oxygen metabolism parameters as well as 24-h survival rate, inhibited the increases in the miR-155-5p and miR-145-5p levels and attenuated myocardial injury in a porcine model of CA and resuscitation.

Entities:  

Keywords:  Post-resuscitation myocardial dysfunction; Sildenafil; miR-145-5p; miR-155-5p

Mesh:

Substances:

Year:  2021        PMID: 33407761      PMCID: PMC7787123          DOI: 10.1186/s13049-020-00819-5

Source DB:  PubMed          Journal:  Scand J Trauma Resusc Emerg Med        ISSN: 1757-7241            Impact factor:   2.953


  30 in total

1.  Aspirin prevents TNF-α-induced endothelial cell dysfunction by regulating the NF-κB-dependent miR-155/eNOS pathway: Role of a miR-155/eNOS axis in preeclampsia.

Authors:  Joohwan Kim; Kyu-Sun Lee; Ji-Hee Kim; Dong-Keon Lee; Minsik Park; Seunghwan Choi; Wonjin Park; Suji Kim; Yoon Kyung Choi; Jong Yun Hwang; Jongseon Choe; Moo-Ho Won; Dooil Jeoung; Hansoo Lee; Sungwoo Ryoo; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  Free Radic Biol Med       Date:  2017-01-11       Impact factor: 7.376

2.  Nitric oxide synthase in cultured endocardial cells of the pig.

Authors:  R Schulz; J A Smith; M J Lewis; S Moncada
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

3.  miRNA-145 is associated with spontaneous hypertension by targeting SLC7A1.

Authors:  Yong Wang; Liyan Jin
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

4.  Differences of postresuscitation myocardial dysfunction in ventricular fibrillation versus asphyxiation.

Authors:  Cai-Jun Wu; Chun-Sheng Li; Yi Zhang; Jun Yang; Qin Yin; Chen-Chen Hang
Journal:  Am J Emerg Med       Date:  2013-09-14       Impact factor: 2.469

5.  MicroRNA-155 aggravates ischemia-reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burst.

Authors:  Steffen U Eisenhardt; Jakob B W Weiss; Christian Smolka; Johanna Maxeiner; Franziska Pankratz; Xavier Bemtgen; Max Kustermann; Jan R Thiele; Yvonne Schmidt; G Bjoern Stark; Martin Moser; Christoph Bode; Sebastian Grundmann
Journal:  Basic Res Cardiol       Date:  2015-04-28       Impact factor: 17.165

6.  Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

Authors:  Donato Santovito; Claudia Mandolini; Pamela Marcantonio; Velia De Nardis; Marco Bucci; Camilla Paganelli; Francesco Magnacca; Sante Ucchino; Daniela Mastroiacovo; Giovambattista Desideri; Andrea Mezzetti; Francesco Cipollone
Journal:  Expert Opin Ther Targets       Date:  2013-01-23       Impact factor: 6.902

7.  Triptolide inhibits angiogenesis in microvascular endothelial cells through regulation of miR-92a.

Authors:  Xiaomeng Xu; Li Tian; Zhimian Zhang
Journal:  J Physiol Biochem       Date:  2019-11-05       Impact factor: 5.080

8.  The effects of phosphodiesterase-5 inhibitor sildenafil against post-resuscitation myocardial and intestinal microcirculatory dysfunction by attenuating apoptosis and regulating microRNAs expression: essential role of nitric oxide syntheses signaling.

Authors:  Qian Zhang; Guoxing Wang; Wei Yuan; Junyuan Wu; Miaomiao Wang; ChunSheng Li
Journal:  J Transl Med       Date:  2015-06-04       Impact factor: 5.531

9.  The protective effects of a phosphodiesterase 5 inhibitor, sildenafil, on postresuscitation cardiac dysfunction of cardiac arrest: metabolic evidence from microdialysis.

Authors:  Qian Zhang; Wei Yuan; Guoxing Wang; Junyuan Wu; Miaomiao Wang; ChunSheng Li
Journal:  Crit Care       Date:  2014-12-05       Impact factor: 9.097

10.  The Protective Effect of rhBNP on Postresuscitation Myocardial Dysfunction in a Rat Cardiac Arrest Model.

Authors:  Min Yang; Tianfeng Hua; Zhengfei Yang; Limin Chen; Yangyang Zou; Xiaohui Huang; Jun Li
Journal:  Biomed Res Int       Date:  2020-02-17       Impact factor: 3.411

View more
  1 in total

1.  lncRNA ADAMTS9-AS1/circFN1 Competitively Binds to miR-206 to Elevate the Expression of ACTB, Thus Inducing Hypertrophic Cardiomyopathy.

Authors:  Wei Feng; Shuo Han
Journal:  Oxid Med Cell Longev       Date:  2022-03-31       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.